Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Bryan Wahl

General Counsel at Tarsus Pharmaceuticals, Inc. (TARS)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $850K

Reported trades

Filed Stock Type Shares Price Value Since
Mar 19SEC TARSTarsus Pharmaceuticals, Inc. Sell 4,08472,315 held (−5%) $69.42 $284K -1.9%
Mar 19SEC TARSTarsus Pharmaceuticals, Inc. Sell 4,12568,190 held (−6%) $68.71 $283K -0.9%
Mar 19SEC TARSTarsus Pharmaceuticals, Inc. Sell 4,23163,959 held (−6%) $67.00 $283K +1.6%